Home/Lusis/Chi Chen
CC

Chi Chen

CEO

Lusis

Therapeutic Areas

Lusis Pipeline

DrugIndicationPhase
VeraPoint qPCR Assay Portfolio ExpansionVarious Infectious Diseases (Respiratory, UTI, STI, GI, Wound, Bloodborne, AMR)Commercial
Q-Vera / Q-Vera Pico InstrumentsqPCR InstrumentationCommercial Launch